2026_Oct_CPHI_Milan_Leaderboard

Cambridge Consultants

Cambridge Consultants is a large product development engineering and technology consultancy with significant interests, expertise and track record in drug delivery, including respiratory (MDIs, DPIs, nebulisers), parenteral (pens, autoinjectors, wearables), and connectivity.

Europe Office
Cambridge Consultants Ltd
Science Park
Milton Road
Cambridge CB4 0DW
United Kingdom

Phone / Contact

T: +44 1223 420024

Articles by Cambridge Consultants

Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device

Liz Proos and Ashley Hawson talk exclusively with ONdrugDelivery's Guy Furness about the DARE Intelligent Drug Delivery System – an advanced, connected implantable device that delivers programmable doses for up to a decade – its place in the market, the challenges faced during its design and its potential as novel drug delivery device.

Alejandra Sanchez

DRUG DELIVERY DEVICE INNOVATION IN CELL AND GENE THERAPIES

Dr Alejandra Sanchez and Charlie Dean consider the evolution of drug delivery technologies and how cell and gene therapies are showing promise as a new class of medicine to correct disease at its source.

NEXT-GENERATION AUTOINJECTORS: BALANCING PATIENTS, PHARMA, PAYERS AND PLANET

David Latham, Matthew Allen and Charlie Dean use a case study of a reusable electromechanical autoinjector to outline the novel product development approach needed to achieve better outcomes for patients, pharma, payers and the planet.

ACCELERATING COMBINATION PRODUCT DEVELOPMENT USING DIGITAL TWIN TECHNOLOGY

Dan Cowen, Sebastian White and Anthony Robinson, discuss the value that implementing a digital twin could provide to drug delivery device design across multiple stages of a development programme.

SUSTAINABLE BY DESIGN: DEVELOPING PATIENT- AND PLANET-CENTRIC MEDICAL DEVICES

Su Osorio, Stephanie Mou and Charlie Dean, explore the delicate balance between patient and planet centricity and propose a user- and planet-centric approach for the development of sustainable medical devices.

Paramesh Natarajan

HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN

Paramesh Natarajan, Shadi Bavar and Charlie Dean present the case for using screening lifecycle assessments to lead into more detailed targeted and comprehensive lifecycle assessments focused on the areas of greatest environmental impact, using a screening lifecycle assessment of a hypothetical body-worn injector as an example.

Dr Suresh Gupta

DRUG DELIVERY TO THE EYE: OVERCOMING THE CHALLENGES OF INTRAVITREAL PREFILLED SYRINGES

Suresh Gupta discusses the challenges of developing a PFS product for intravitreal injection, highlighting how designing for the intravitreal space, rather than the standard parenteral, imposes a number of additional requirements on the design.

DEVICE DESIGN CONSULTANCIES JOIN FORCES, STEP-UP TO THE COVID-19 VENTILATOR CHALLENGE

Leading device design consultancies Cambridge Consultants, PA Consulting, Sagentia, Team Consulting and TTP , with industrial assistance from MetLase, have joined forces to answer the UK government's call for the rapid development and manufacture of vital ventilators for patients suffering with severe symptoms of COVID-19.

Dr James Blakemore

LARGE VOLUME INJECTION – BEYOND VOLUME AND VISCOSITY

James Blakemore uncovers the underlying reasons that drive the use of large volume injectors and make the case for a more extensive use of such devices based on the broader-than-expected purposes they can serve.

IT’S JUST AN APP, ISN’T IT?

Vaishali Kamat and Jaquie Finn, outline some key questions that pharma companies should ask before embarking on the development of a connected health solution, and provide insights that could help companies make the most from their investment.

Top